Baojun Liu

No. 12 Urumqi MIDDLE Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Reprogrammed Fibrotic Niche Fuels Lung Cancer Initiation and Reciprocal Remodeling.

Reprogrammed Fibrotic Niche Fuels Lung Cancer Initiation and Reciprocal Remodeling.

Journal: International journal of biological sciences

Published: October 25, 2025

scRNA-sequencing Reveals Bu-Shen-Yi-Qi formula (BSYQF) ameliorates airway remodeling via regulating imbalanced M1/M2 macrophage subtypes in chronic asthmatic mice.

scRNA-sequencing Reveals Bu-Shen-Yi-Qi formula (BSYQF) ameliorates airway remodeling via regulating imbalanced M1/M2 macrophage subtypes in chronic asthmatic mice.

Journal: Journal of ethnopharmacology

Published: July 22, 2025

Norgestrel shows androgenic properties and triggers reproductive neuroendocrine toxicity in the testes of Pacific oysters (Crassostrea gigas).

Norgestrel shows androgenic properties and triggers reproductive neuroendocrine toxicity in the testes of Pacific oysters (Crassostrea gigas).

Journal: Journal of hazardous materials

Published: January 02, 2025

Icariside II in NSCLC and COVID-19: Network pharmacology and molecular docking study.

Icariside II in NSCLC and COVID-19: Network pharmacology and molecular docking study.

Journal: The journal of gene medicine

Published: November 02, 2023

Modified Bushen Yiqi Formula mitigates pulmonary inflammation and airway remodeling by inhibiting neutrophils chemotaxis and IL17 signaling pathway in rats with COPD.

Modified Bushen Yiqi Formula mitigates pulmonary inflammation and airway remodeling by inhibiting neutrophils chemotaxis and IL17 signaling pathway in rats with COPD.

Journal: Journal of ethnopharmacology

Published: September 10, 2023

Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.

Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.

Journal: Journal of ethnopharmacology

Published: August 02, 2023

Intratumoral Heterogeneity in Lung Cancer.

Intratumoral Heterogeneity in Lung Cancer.

Journal: Cancers

Published: April 19, 2023

Correction: Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.

Correction: Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 24, 2023

Inhibition of Non-small Cell Lung Cancer by Ferroptosis and Apoptosis Induction through P53 and GSK-3β/Nrf2 Signal Pathways using Qingrehuoxue Formula.

Inhibition of Non-small Cell Lung Cancer by Ferroptosis and Apoptosis Induction through P53 and GSK-3β/Nrf2 Signal Pathways using Qingrehuoxue Formula.

Journal: Journal of Cancer

Published: October 01, 2022

TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice.

TMT-Based Quantitative Proteomic Analysis Reveals Downregulation of ITGAL and Syk by the Effects of Cycloastragenol in OVA-Induced Asthmatic Mice.

Journal: Oxidative medicine and cellular longevity

Published: May 19, 2022

Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways.

Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 27, 2022

Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway.

Gypenosides Attenuate Pulmonary Fibrosis by Inhibiting the AKT/mTOR/c-Myc Pathway.

Journal: Frontiers in pharmacology

Published: October 31, 2021

Showing 1-12 of 44

Last Updated: 09/26/2026